JEMA Calls for Disclosure of Expected 3-Month Inventory Levels, Smaller Number of Companies per API

JEMA Chairman Hiroshi Matsumori The Japan Established Medicine Association (JEMA) announced on November 30 a proposal to improve the stability of generic drug supplies, calling on manufacturers to inform medical institutions of expected three month inventory levels of their products...read more